TMC-GCID Publications

Found 26 results
Xing Y, Clark JR, Chang JD, Chirman DM, Green S, Zulk JJ, et al.. Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 ;19(2):e1011082.
B Ayyar V, Ettayebi K, Salmen W, Karandikar UC, Neill FH, Tenge VR, et al.. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 ;14(1):1148.
Carter H, Clark J, Carlin LG, Vaughan E, Rajan A, Olvera A, et al.. Functional Genomics of Gastrointestinal Isolated from Patients with Cancer and Diarrhea. bioRxiv. 2023 ;.
Adeniyi-Ipadeola GO, Hankins JD, Kambal A, Zeng X-L, Patil K, Poplaski V, et al.. Infant and Adult Human Intestinal Enteroids are Morphologically and Functionally Distinct. bioRxiv. 2023 ;.
Dylus D, Altenhoff A, Majidian S, Sedlazeck FJ, Dessimoz C. Inference of phylogenetic trees directly from raw sequencing reads using Read2Tree. Nat Biotechnol. 2023 ;.
Avadhanula V, Creighton C, Ferlic-Stark L, Sucgang R, Zhang Y, Nagaraj D, et al.. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. Res Sq. 2023 ;.
Su L, Huang W, Neill FH, Estes MK, Atmar RL, Palzkill T. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. NPJ Vaccines. 2023 ;8(1):87.
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 ;.
Clark JR, Maresso AM. Comparative Pathogenomics of : Polyvalent Vaccine Target Identification through Virulome Analysis. Infect Immun. 2021 ;89(8):e0011521.
Criss ZK, Bhasin N, Di Rienzi SC, Rajan A, Deans-Fielder K, Swaminathan G, et al.. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 ;53(11):486-508.
Olvera A, Carter H, Rajan A, Carlin LG, Yu X, Zeng X-L, et al.. Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients. Clin Infect Dis. 2021 ;72(10):e620-e629.
Rajan A, Weaver AMorgan, Aloisio GMarie, Jelinski J, Johnson HL, Venable SF, et al.. The Human Nose Organoid Respiratory Virus Model: an Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 ;13(1):e0351121.
Chen F, Zhang Y, Sucgang R, Ramani S, Corry D, Kheradmand F, et al.. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors. Sci Rep. 2021 ;11(1):2459.
Doddapaneni H, Cregeen SJavornik, Sucgang R, Meng Q, Qin X, Avadhanula V, et al.. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. PLoS One. 2021 ;16(8):e0244468.
Sapoval N, Mahmoud M, Jochum MD, Liu Y, Elworth RALeo, Wang Q, et al.. SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission. Genome Res. 2021 ;31(4):635-644.
Butler D, Mozsary C, Meydan C, Foox J, Rosiene J, Shaiber A, et al.. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021 ;12(1):1660.
Farinholt T, Doddapaneni H, Qin X, Menon V, Meng Q, Metcalf G, et al.. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections. BMC Med. 2021 ;19(1):255.